|Articles|October 19, 2007

A Healthy Outlook for Oncology?

The oncology market has experienced ten remarkable years. But is the 'Golden Age' coming to an end? IMS Health looks at the changing economics of the cancer industry in Pharm Exec Europe's new e-supplement.

The oncology market has experienced ten remarkable years. But is the 'Golden Age' coming to an end?

IMS Health looks at the changing economics of the cancer industry in Pharm Exec Europe's new e-supplement.

Click here to see the supplement.

 

 

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content